Patient-Reported Outcomes of Treatment of Opioid Dependence With Weekly and Monthly Subcutaneous Depot vs Daily Sublingual Buprenorphine: A Randomized Clinical Trial.
Sign Up to like & getrecommendations! Published in 2021 at "JAMA network open"
DOI: 10.1001/jamanetworkopen.2021.9041
Abstract: Importance Patient-reported outcomes in the treatment of opioid dependence may differ between subcutaneously administered depot buprenorphine and daily sublingual buprenorphine. Objective To compare patient satisfaction between depot buprenorphine and sublingual buprenorphine in adult outpatients with… read more here.
Keywords: trial; treatment; sublingual buprenorphine; buprenorphine ... See more keywords
Pharmacokinetic Evaluation of Once-Weekly and Once-Monthly Buprenorphine Subcutaneous Injection Depots (CAM2038) Versus Intravenous and Sublingual Buprenorphine in Healthy Volunteers Under Naltrexone Blockade: An Open-Label Phase 1 Study
Sign Up to like & getrecommendations! Published in 2017 at "Advances in Therapy"
DOI: 10.1007/s12325-016-0472-9
Abstract: AbstractIntroductionCAM2038 q1w (once weekly) and q4w (once monthly) are investigational buprenorphine subcutaneous (SC) formulations based on FluidCrystal® injection depot technology. These two drug products are being developed for opioid dependence treatment, with a target for… read more here.
Keywords: treatment; cam2038 q1w; sublingual buprenorphine; cam2038 ... See more keywords
Sublingual buprenorphine versus intravenous or intramuscular morphine in acute pain: A systematic review and meta‐analysis of randomized control trials
Sign Up to like & getrecommendations! Published in 2019 at "American Journal of Emergency Medicine"
DOI: 10.1016/j.ajem.2018.05.052
Abstract: Intro Buprenorphine is a potent analgesic agent with several unique and favourable features such as its sublingual formulation. The aim of this study is to compare the effectiveness of sublingual versus intramuscular and intravenous buprenorphine… read more here.
Keywords: buprenorphine; sublingual buprenorphine; acute pain; intravenous intramuscular ... See more keywords
Sublingual buprenorphine-naloxone precipitated withdrawal-A case report with review of literature and clinical considerations.
Sign Up to like & getrecommendations! Published in 2020 at "Asian journal of psychiatry"
DOI: 10.1016/j.ajp.2020.102121
Abstract: Buprenorphine- Naloxone Fixed Dose Combination (BNX) is widely used to manage opioid use disorders. Contrary to evidence based concepts about sublingual bio-availability of naloxone, a few small studies have reported non-negligible amounts absorbed sublingually. But… read more here.
Keywords: sublingual buprenorphine; report; buprenorphine naloxone; case ... See more keywords
Sublingual Buprenorphine for Pediatric Cancer Pain: A Case Report and Review of the Literature.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of pain and symptom management"
DOI: 10.1016/j.jpainsymman.2020.07.029
Abstract: Pain is a common symptom in pediatric patients with cancer, and the majority of these patients in palliative care will receive opioids. Traditional opioids have several drawbacks, including their adverse effects, inconsistent or diminishing efficacy,… read more here.
Keywords: buprenorphine pediatric; sublingual buprenorphine; cancer; buprenorphine ... See more keywords
Prolonged-release buprenorphine formulations: Perspectives for clinical practice.
Sign Up to like & getrecommendations! Published in 2020 at "Therapie"
DOI: 10.1016/j.therap.2020.05.007
Abstract: Buprenorphine and methadone are the two main opioid agonist treatments approved for opioid use disorder. Buprenorphine is a partial agonist of the mu opioid receptors, which has been merely available through sublingual form until now.… read more here.
Keywords: release buprenorphine; sublingual buprenorphine; prolonged release; practice ... See more keywords
[Prolonged-release buprenorphine formulations: Perspectives for clinical practice].
Sign Up to like & getrecommendations! Published in 2020 at "Therapie"
DOI: 10.1016/j.therap.2020.05.008
Abstract: Buprenorphine and methadone are the two main opioids agonist treatments approved for opioid use disorder. Buprenorphine is a partial agonist of the mu-opioid receptors, which has been merely available through sublingual form until now. In… read more here.
Keywords: release buprenorphine; sublingual buprenorphine; prolonged release; practice ... See more keywords
Comparison of Neonatal Abstinence Syndrome Treatment with Sublingual Buprenorphine versus Conventional Opioids
Sign Up to like & getrecommendations! Published in 2018 at "American Journal of Perinatology"
DOI: 10.1055/s-0037-1608634
Abstract: Objective The objective of this study was to compare duration of opioid treatment and length of stay outcomes for neonatal abstinence syndrome (NAS) using sublingual buprenorphine versus traditional weaning with methadone or morphine. Study Design… read more here.
Keywords: abstinence syndrome; treatment; buprenorphine versus; sublingual buprenorphine ... See more keywords
Transdermal buprenorphine for in-hospital transition from full agonist opioids to sublingual buprenorphine: a retrospective observational cohort study
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Toxicology"
DOI: 10.1080/15563650.2022.2028802
Abstract: Abstract Introduction Patients with opioid use disorder may have difficulty transitioning from full-agonist opioids to sublingual buprenorphine due to the risk of precipitated opioid withdrawal. Novel strategies have been developed to facilitate this transition, including… read more here.
Keywords: sublingual buprenorphine; transdermal buprenorphine; buprenorphine; full agonist ... See more keywords
Using Extended Release Buprenorphine Injection to Discontinue Sublingual Buprenorphine: A Case Series.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of addiction medicine"
DOI: 10.1097/adm.0000000000000738
Abstract: : Buprenorphine is highly effective for the treatment of opioid use disorder and is increasingly being used in the treatment of chronic pain. For various reasons, patients on buprenorphine may request discontinuation of this medication.… read more here.
Keywords: release buprenorphine; sublingual buprenorphine; injection; extended release ... See more keywords
48-hour Induction of Transdermal Buprenorphine to Sublingual Buprenorphine/Naloxone: The IPPAS Method.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of addiction medicine"
DOI: 10.1097/adm.0000000000001072
Abstract: Buprenorphine is an effective medication for the treatment of opioid use disorder. However, the traditional method of buprenorphine induction requires a period of abstinence and the development of at least moderate withdrawal, which can be… read more here.
Keywords: sublingual buprenorphine; transdermal buprenorphine; buprenorphine; buprenorphine naloxone ... See more keywords